SEC 13F Intelligence

Hanseatic Management Services Inc / ISI

Hanseatic Management Services Inc’s Ionis Pharmaceuticals Inc Position

Does Hanseatic Management Services Inc own Ionis Pharmaceuticals Inc (ISI)? Not currently — the last reported position was 10.8K shares worth $408 in Q4 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$408
Q4 2022
Shares
10.8K
% of Portfolio
+1.03%
Quarters Held
7
position exited

Position History ISI

Reported value by quarter
Q4 ’18: $440,000Q4 ’18Q1 ’19: $700,000Q1 ’19Q2 ’19: $534,000Q2 ’19Q3 ’19: $498,000Q3 ’19Q2 ’22: $415,000Q2 ’22Q3 ’22: $486,000Q3 ’22Q4 ’22: $408Q4 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202210.8K$408+1.03%
Q3 202211.0K$486,000+1.31%
Q2 202211.2K$415,000+0.94%
Q3 20198.3K$498,000+0.51%
Q2 20198.3K$534,000+0.54%
Q1 20198.6K$700,000+0.73%
Q4 20188.1K$440,000+0.59%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hanseatic Management Services Inc’s full portfolio or all institutional holders of ISI.